March 11, 2026 11:52 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Supreme Court allows first-ever passive euthanasia for 32-year-old man in coma for 13 years | As Iran-US war disrupts global gas supply, India issues guidelines to manage shortages | LPG crisis hits metros: Commercial cylinder shortage triggers panic as govt prioritises domestic supply | Iran war disrupts LPG supplies, restaurants in major Indian cities edge towards shutdown | ‘How dare you question judicial officers?’: SC raps Bengal SIR pleas, orders appellate tribunals for voter list appeals | 'Book withdrawn': NCERT apologises for controversial judiciary chapter after Supreme Court ban | Indian stock market surges as Brent crude dips below $100 after Trump’s Iran remarks | Australia grants asylum to five Iranian women footballers after anthem protest; Albanese says ‘they are safe here’ | Trump administration labels Afghanistan ‘state sponsor of wrongful detention’ | Trump threatens Iran with ‘20 times harder’ strike if oil flow through Strait of Hormuz is disrupted
iNCOVACC
Image credit: Bharat Biotech Twitter

Bharat Biotech's intranasal COVID-19 vaccine to be launched on Republic Day

| @indiablooms | Jan 22, 2023, at 11:37 pm

Bhopal: Hyderabad-based vaccine maker Bharat Biotech is all set to launch its intranasal COVID-19 vaccine iNCOVACC on January 26, the company's chairman and managing director Krishna Ella said here on Saturday.

"Our nasal vaccine will be officially launched on January 26, on Republic Day," Ella said, participating in the 'Face-to-Face with New Frontiers in Science' segment of the IISF, organised at the Maulana Azad National Institute of Technology (MANIT).

While interacting with students at the India International Science Festival in Bhopal, he also said that the indigenous vaccine for the lumpy skin disease in cattle, Lumpi-ProVacInd, is expected to be launched next month.

iNCOVACC vaccine, the first of its kind in India, would be sold for Rs 325 per shot for procurement by the government and Rs 800 per shot for private vaccination centres, Bharat Biotech had said in December 2022.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.